Nanotherapeutics Engineered to Cross the Blood-Brain Barrier for Advanced Drug Delivery to the Central Nervous System

Overview

Journal J Ind Eng Chem

Date 2019 Oct 8

PMID 31588177

Citations 28

Authors

Jinhwan Kim

Song Ih Ahn

YongTae Kim

Affiliations

Soon will be listed here.

Abstract

Drug delivery to the brain remains challenging mainly due to the blood-brain barrier (BBB) that regulates the entrance of substances to the brain. Advances in nanotechnology have enabled the engineering of nanomedicines for biomedical applications including enhanced drug delivery into the brain. In this review, we describe strategies of nanomedicines engineered to traverse the BBB and deliver therapeutic molecules to target brain sites. We highlight the representative applications with materials including polymers, lipids, and inorganic elements for brain drug delivery. We finalize this review with the current challenges and future perspective of nanotherapeutics for advanced drug delivery to the brain.

Citing Articles

Metal nanoparticles in neuroinflammation: impact on microglial dynamics and CNS function.

Alaei M, Koushki K, Taebi K, Yousefi Taba M, Keshavarz Hedayati S, Shahbaz S RSC Adv. 2025; 15(7):5426-5451.

PMID: 39967886 PMC: 11833603. DOI: 10.1039/d4ra07798a.

Asoprisnil as a Novel Ligand Interacting with Stress-Associated Glucocorticoid Receptor.

Ejiohuo O, Bajia D, Pawlak J, Szczepankiewicz A Biomedicines. 2025; 12(12.

PMID: 39767652 PMC: 11726916. DOI: 10.3390/biomedicines12122745.

Advancements and challenges in brain cancer therapeutics.

Bai F, Deng Y, Li L, Lv M, Razzokov J, Xu Q Exploration (Beijing). 2024; 4(6):20230177.

PMID: 39713205 PMC: 11655316. DOI: 10.1002/EXP.20230177.

Advancements in nanotheranostics for glioma therapy.

Sahoo L, Paikray S, Tripathy N, Fernandes D, Dilnawaz F Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39480526 DOI: 10.1007/s00210-024-03559-w.

Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements.

Nayak U, Halagali P, Panchal K, Panchal K, Tippavajhala V, Tippavajhala V Curr Pharm Des. 2024; 31(6):443-460.

PMID: 39318210 DOI: 10.2174/0113816128328722240828184410.

References

Clark A, Davis M . Increased brain uptake of targeted nanoparticles by adding an acid-cleavable linkage between transferrin and the nanoparticle core. Proc Natl Acad Sci U S A. 2015; 112(40):12486-91. PMC: 4603510. DOI: 10.1073/pnas.1517048112. View

Robert J, Stukas S, Button E, Cheng W, Lee M, Fan J . Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice. Biochim Biophys Acta. 2015; 1862(5):1027-36. DOI: 10.1016/j.bbadis.2015.10.005. View

Nance E, Woodworth G, Sailor K, Shih T, Xu Q, Swaminathan G . A dense poly(ethylene glycol) coating improves penetration of large polymeric nanoparticles within brain tissue. Sci Transl Med. 2012; 4(149):149ra119. PMC: 3718558. DOI: 10.1126/scitranslmed.3003594. View

Charest G, Sanche L, Fortin D, Mathieu D, Paquette B . Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain. J Neurooncol. 2013; 115(3):365-73. PMC: 3829823. DOI: 10.1007/s11060-013-1238-8. View

Pardridge W . Blood-brain barrier drug targeting: the future of brain drug development. Mol Interv. 2004; 3(2):90-105, 51. DOI: 10.1124/mi.3.2.90. View

Lin C, Lu T . C60 fullerene derivatized nanoparticles and their application to therapeutics. Recent Pat Nanotechnol. 2012; 6(2):105-13. DOI: 10.2174/187221012800270135. View

Liu Y, Mei L, Yu Q, Xu C, Qiu Y, Yang Y . Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma. ACS Appl Mater Interfaces. 2015; 7(30):16792-801. DOI: 10.1021/acsami.5b04596. View

Jiang X, Xin H, Ren Q, Gu J, Zhu L, Du F . Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. Biomaterials. 2013; 35(1):518-29. DOI: 10.1016/j.biomaterials.2013.09.094. View

Furtado D, Bjornmalm M, Ayton S, Bush A, Kempe K, Caruso F . Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases. Adv Mater. 2018; 30(46):e1801362. DOI: 10.1002/adma.201801362. View

10.

Kuai R, Li D, Chen Y, Moon J, Schwendeman A . High-Density Lipoproteins: Nature's Multifunctional Nanoparticles. ACS Nano. 2016; 10(3):3015-41. PMC: 4918468. DOI: 10.1021/acsnano.5b07522. View

11.

Zhou J, Patel T, Sirianni R, Strohbehn G, Zheng M, Duong N . Highly penetrative, drug-loaded nanocarriers improve treatment of glioblastoma. Proc Natl Acad Sci U S A. 2013; 110(29):11751-6. PMC: 3718184. DOI: 10.1073/pnas.1304504110. View

12.

Huang M, Hu M, Song Q, Song H, Huang J, Gu X . GM1-Modified Lipoprotein-like Nanoparticle: Multifunctional Nanoplatform for the Combination Therapy of Alzheimer's Disease. ACS Nano. 2015; 9(11):10801-16. DOI: 10.1021/acsnano.5b03124. View

13.

Song Q, Song H, Xu J, Huang J, Hu M, Gu X . Biomimetic ApoE-Reconstituted High Density Lipoprotein Nanocarrier for Blood-Brain Barrier Penetration and Amyloid Beta-Targeting Drug Delivery. Mol Pharm. 2016; 13(11):3976-3987. DOI: 10.1021/acs.molpharmaceut.6b00781. View

14.

Chekhonin V, Baklaushev V, Yusubalieva G, Belorusova A, Gulyaev M, Tsitrin E . Targeted delivery of liposomal nanocontainers to the peritumoral zone of glioma by means of monoclonal antibodies against GFAP and the extracellular loop of Cx43. Nanomedicine. 2011; 8(1):63-70. DOI: 10.1016/j.nano.2011.05.011. View

15.

Rathore A, Winkle H . Quality by design for biopharmaceuticals. Nat Biotechnol. 2009; 27(1):26-34. DOI: 10.1038/nbt0109-26. View

16.

Tsou Y, Zhang X, Zhu H, Syed S, Xu X . Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials. Small. 2017; 13(43). DOI: 10.1002/smll.201701921. View

17.

Hu Q, Gao X, Gu G, Kang T, Tu Y, Liu Z . Glioma therapy using tumor homing and penetrating peptide-functionalized PEG-PLA nanoparticles loaded with paclitaxel. Biomaterials. 2013; 34(22):5640-50. DOI: 10.1016/j.biomaterials.2013.04.025. View

18.

Kolter M, Ott M, Hauer C, Reimold I, Fricker G . Nanotoxicity of poly(n-butylcyano-acrylate) nanoparticles at the blood-brain barrier, in human whole blood and in vivo. J Control Release. 2014; 197:165-79. DOI: 10.1016/j.jconrel.2014.11.005. View

19.

Blanco E, Shen H, Ferrari M . Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015; 33(9):941-51. PMC: 4978509. DOI: 10.1038/nbt.3330. View

20.

Gong W, Wang Z, Liu N, Lin W, Wang X, Xu D . Improving efficiency of adriamycin crossing blood brain barrier by combination of thermosensitive liposomes and hyperthermia. Biol Pharm Bull. 2011; 34(7):1058-64. DOI: 10.1248/bpb.34.1058. View